Compare · STI vs TMO
STI vs TMO
Side-by-side comparison of Solidion Technology Inc. (STI) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- STI operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $197.88B, about 3679.6x STI ($53.8M).
- Over the past year, STI is up 31.4% and TMO is up 28.1% - STI leads by 3.3 points.
- TMO has been more active in the news (9 items in the past 4 weeks vs 5 for STI).
- TMO has more recent analyst coverage (25 ratings vs 0 for STI).
- Company
- Solidion Technology Inc.
- Thermo Fisher Scientific Inc
- Price
- $6.23-1.74%
- $532.16-2.05%
- Market cap
- $53.8M
- $197.88B
- 1M return
- -69.70%
- +12.59%
- 1Y return
- +31.43%
- +28.12%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 5
- 9
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest STI
- Solidion Technology Inc. filed SEC Form 8-K: Shareholder Director Nominations, Other Events
- Solidion Technology (Nasdaq: STI) Adopts SpaceX-Focused Treasury Strategy for Corporate Cash Reserves
- SEC Form D filed by Solidion Technology Inc.
- SEC Form 424B3 filed by Solidion Technology Inc.
- SEC Form EFFECT filed by Solidion Technology Inc.
- Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and Infrastructure
- SEC Form S-1 filed by Solidion Technology Inc.
- Large owner Ikezi Henry bought $643,965 worth of shares (26,000 units at $24.77), sold $12,212,372 worth of shares (394,888 units at $30.93), disposed of 214,037 shares, acquired 214,037 shares and exercised 214,037 shares at a strike of $3.10 (SEC Form 4)
- Solidion Technology Announces Closing of $35 Million Private Placement of Common Stock Priced Above Market Under Nasdaq Rules
- Solidion Technology Withdraws Previously Filed Registration Statement
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target